| Baseline before intervention phase | 16-week intervention phase (1) after randomization into control group and experimental group | After intervention phase | 6-month follow-up | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Visits | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
Weeks | −1 | 1 | 2 | 4 | 6 | 8 | 10 | 12 | 14 | 16 | 16 + 1 | 16 + 26 |
Personal Physiotherapy Consultation (PT) | Â | PT1 | PT2 | PT3 | PT4 | PT5 | PT6 | PT7 | PT8 | PT9 | Â | Â |
Primary outcome | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 ICIO-UIsf | x |  | x | x | x | x | x | x | x | x | x |  |
Secondary outcomes | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 EMG (rest, MVC) | x |  |  |  |  |  |  |  |  |  | x | x |
 EMG (VFC, SJ, CMJ, DJ) | x |  |  |  |  |  |  |  |  |  | x | x |
 EMG (running 7, 9, 11 km/h) | x |  |  |  |  |  |  |  |  |  | x | x |
 ICIQ-UIsf |  |  |  |  |  |  |  |  |  |  |  | x |
 ICIQ-LUTSqol | x |  |  |  |  |  |  |  |  |  | x | x |
 20-min pad test | x |  |  |  |  |  |  |  |  |  | x | x |
Tertiary outcomes | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Manual muscle testing | x |  |  |  |  |  |  |  |  |  | x | x |
 Therapy adherence |  |  | x | x | x | x | x | x | x | x | x | x |